MedPath

Effect of the dual treatment of diquafosol sodium and rebamipide on dry eye syndrome related to chronic graft versus host disease and Sjogrens syndrome

Not Applicable
Conditions
Dry eye related to chronic GVHD and Sjogren s syndrome
Registration Number
JPRN-UMIN000013234
Lead Sponsor
Keio University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1, Dry eye syndrome severity level 4 (dry eye workshop classification 2007) 2, Patients dosed diquafosol sodium and / or rebamipide ophthalmic solution 3, Patients having a concern of becoming severe dry eye because of having GVHD in other organs and so on 4, Patients with ocular pemphigoid, and Stevens-Johnson syndrome 5, Patients with a history of ophthalmic surgery within 6 months before the study 6, Patients wearing contact lens 7, Patients who will be applied radiation treatment during the study 8, Patients dosed cevimeline hydrochloride hydrate and /or pilocarpine(eye drop or oral drug) 9, Patients who will be ineligible for registration the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anterior ocular segment remark Corneal sensitivity Schirmer test Tear film breakup time Fluorescein staining Rose bengal staining Subjective symptom
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath